Five Qidu Pharma Products Selected in China's 10th National Drug Procurement Program

On December 12, the 10th National Volume-Based Drug Procurement (VBP) tender was held in Shanghai. Shandong Qidu Pharmaceutical Co., Ltd. had five products successfully selected:  

1. Ciprofloxacin Lactate and Sodium Chloride Injection

2. Pentoxifylline Injection

3. Sodium Bicarbonate Ringer's Injection

4. Sodium Lactate Ringer's Injection

5. Potassium Chloride Injection

Product Details

1. Ciprofloxacin Lactate and Sodium Chloride Injection

- Specification: 100ml:0.2g:0.9g

- Packaging: Polypropylene (PP) infusion bottle

- Features:

  - One of the most potent fluoroquinolone antibiotics against Pseudomonas aeruginosa

  - Widely used for skin/soft tissue infections, bone/joint infections, intra-abdominal infections, respiratory infections, and genitourinary infections

  - Broad-spectrum, excellent tissue penetration, and high efficacy  

  - Listed in China National Reimbursement Drug List (NRDL) Class B and National Essential Medicines List

2. Pentoxifylline Injection

Specification: 5ml:0.1g  

Packaging: PP ampoule  

Features:

  - A non-specific peripheral vasodilator with multiple mechanisms (vasodilation, microcirculation improvement, antiplatelet aggregation)  

  - Used for cerebral/peripheral circulatory disorders and inner ear blood flow issues

  - Listed in NRDL Class B

3. Sodium Bicarbonate Ringer's Injection

Specification: 500ml  

Packaging: Multi-layer co-extruded IV bag with outer barrier  

Features:

  - A plasma-adapted compound electrolyte solution for extracellular fluid replenishment

  - Corrects metabolic acidosis during hypovolemia

  - Listed in NRDL Class B

4. Sodium Lactate Ringer's Injection

Specification: 500ml  

Packaging: PP infusion bottle  

Features:

  - Regulates fluid, electrolyte, and acid-base balance

  - Treats metabolic acidosis and dehydration

  - High safety, minimal side effects, and ease of use  

  - Listed in NRDL Class A and National Essential Medicines List

5. Potassium Chloride Injection

- Specification: 10ml:1.5g  

- Packaging: PP ampoule  

- Features:

  - Electrolyte supplement for hypokalemia treatment/prevention

  - Manages digoxin-induced arrhythmias

  - Listed in NRDL Class A and National Essential Medicines List

Manufacturing Capabilities

Qidu Pharma boasts annual production capacities of:  

- 2 billion bottles/bags of large-volume injections  

- 1 billion units of PP ampoule small-volume injections  

Advanced Production Technologies

- Large-Volume Injections:

  - China's most advanced production facility with fully digitized processes

  - Integrated MES, WMS, DMS, LIMS, and drug traceability systems for end-to-end quality control  

- Small-Volume Injections (PP Ampoules):

  - Uses Blow-Fill-Seal (BFS) technology for one-step sterile molding

  - Superior to traditional glass ampoules: no particulates, easy to open, shatterproof, and contamination-resistant

Strategic Impact

The selection of these five products in the 10th VBP round will:  

✔ Optimize market structure

✔ Enhance brand influence and competitiveness

✔ Provide better treatment options for clinicians and patients